Blog

COVID-19: Inhaler can help in reducing COVID symptoms by 90 percent, experts say

Feb, 2021 - By WMR

COVID-19: Inhaler can help in reducing COVID symptoms by 90 percent, experts say

A new way of treatment has emerged to lessen the symptoms of COVID-19. Traditionally it is used to treat chronic obstructive pulmonary disease (COPD) and asthma. Yes inhaler is a new way of reducing the severity of COVID symptoms.

In a study by NIHR Oxford Biomedical Research Centre (BRC), the inhaler budesonide was noticed to lessen the symptoms of severe COVID by 90 percent.

For the research, 146 people were analyzed and half of the people have administrated a budesonide inhaler with a dose of 800 micrograms twice a day. The other half were given a placebo for 28 days. The result was people who were given the inhaler were less likely to require urgent care. Also, they reported lesser long-term symptoms and shorter fever lengths. Thus this inhaler can help in preventing persistent symptoms after the illness, say experts.

The study was encouraged by viewing that only a few chronic asthma patients were being hospitalized during the initial months of the pandemic, which was different from what was assumed. After this study, the experts observed that it was due to the inhaling of corticosteroid inhalers, which has effectively prevented more serious respiratory impacts in these patients.

Other drugs that have been observed to reduce the severity are:

Colchicine drug

Except for budesonide, there are also many other drugs available in the market that can lessen the symptoms of COVID illness. According to a recent Canadian study, which is not yet peer-reviewed, colchicine: the anti-inflammatory gout medication could be beneficial in cutting the rate of hospitalization and death from the SARS-CoV-2 virus.

This drug inexpensive and can be given orally. Moreover, it has lesser-known side effects

Aspirin Drug

A recent study has claimed that people who consume aspirin could experience better COVID results than people who do not take aspirin.

In a recent study published in the journal Anesthesia and Analgesia, the medical records of more than 400 COVID-19 patients were analyzed. Among all these, patients who consumed aspirin daily were found to be 43 percent less likely to require urgent care and 44 percent less likely to be put on a ventilator. Also, these patients were 47 percent less likely to die from the disease as compared to people who did not consume the aspirin.

Xlear: a nasal spray

As per the December study, a simple nasal spray could reduce the severity of novel coronavirus symptoms. The xlear nasal spray was observed to greatly lesser the amount of the active COVID virus only in 25 minutes.

Blood thinners drugs

The blood thinners could be an easy and inexpensive way to reduce complications associated with the COVID-19. Blood clots are common symptoms that occur with COVID, which adversely affect around one-third of severe patients.

As per the study published in The BMJ, researchers analyzed around 4,297 COVID patients from the United States Department of Veterans Affairs, it was observed that patients who were administered blood thinner within 24 hours of hospitalization, their death risk was decreased by 34 percent as compared to patients who were not given blood thinners drugs.

Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2021 Worldwide Market Reports. All rights reserved